Global thyroid pharma economics: T3 meds

Here’s an update on prices in some locations of the world, and Canada, for synthetic T3 medication, known by the chemical name liothyroinine. UNITED KINGDOM & GREECE A Daily Mail article published May 27, 2019 reported the prices for T3 / Liothyronine pills in the UK over time, and today in Greece: 20-25 mcg / day, 1 month UK, 2007, 28 x 20 mcg = £4.46 GBP  = $ 7.61 CAD UK, 2019, 28 x 20 mcg = £204.39 GBP = $348.77 CAD GREECE, 2019, 30 x 25 mcg = £1 GBP = $1.71 CAD Quotations from the article: “Going …

Continue Reading

British endocrinologists agree with Canadian thyroid patient

PRESS RELEASE: “Society for Endocrinology & British Thyroid Association issue statement against new treatment recommendations for subclinical hypothyroidism” On May 24th, my “rapid response letter” was published on the British Medical Journal website. I was responding to newly published recommendations: https://www.bmj.com/content/365/bmj.l2006/rr-6 On May 29th, Several points in this joint statement by the SfE & BTA echo my letter’s content. I’m not claiming that I influenced them, but they agreed with several of my letter’s points 5 days after my letter was published. We are on the same wavelength. 1. I WROTE: “I believe “false-negatives” will genuinely suffer without appropriate therapy if …

Continue Reading
FILED UNDER: UK

Question Pilo’s study: Iodine dosing biases T4:T3 secretion

This post continues my series that examines two ratios T4:T3 thyroid hormone secreted by “the” thyroid gland. The single origin of both these ratios is an article by Pilo et al published in 1990.    A simple summary: In Pilo’s’ study, the huge doses of iodine these 14 people were given every day during the 8-day study could have compromised the amount and ratio of T3 and T4 they secreted from their thyroid glands. The ratio and level could have also shifted over the first few days of the study. These are not natural conditions for thyroid secretion. The findings …

Continue Reading

Question Pilo’s 1990 study. It can be misused to limit your T3 supply.

In this series, I am examining two T4-T3 thyroid hormone ratios that have been circulating in thyroid medical literature for decades. The first ratio is the “molar ratio” of T4 and T3 hormone secretion from the thyroid gland. The second ratio is the theory that the human body derives 20% of its T3 hormone supply from the gland and 80% of its T3 from T4-T3 conversion outside the thyroid. Both of these ratios can be traced back to the averages and numbers given in a single article. The article by Alessandro Pilo and several colleagues in 1990 was titled “Thyroidal and …

Continue Reading

Letter on diagnosis published on British Medical Journal website

Today, the British Medical Journal’s website published my “rapid response” letter: How can truly hypothyroid patients be accurately diagnosed within the enlarged subclinical category? Link to full text: https://www.bmj.com/content/365/bmj.l2006/rr-6 It is a response to the new guidelines for subclinical hypothyroidism: Bekkering, G. E., Agoritsas, T., Lytvyn, L., Heen, A. F., Feller, M., Moutzouri, E., … Vermandere, M. (2019). Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ, 365, l2006. https://doi.org/10.1136/bmj.l2006 Quotes “My main concern with the new guidelines is for the health of patients who are truly hypothyroid despite TSH and T4 levels that place them within the …

Continue Reading